Clinical Trial Update: ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the ShorT and OPtimal Duration of Dual Antiplatelet Therapy-3 study evaluating the optimal duration of dual antiplatelet thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Kyoto University, Graduate School of Medicine | Conditions: Acute Coronary Syndrome | Phase 4 | Status: ACTIVE_NOT_RECRUITING